findmyKOL
Clinical trialNCT03196375TerminatedPhase 2Interventional

A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

SponsorFlex Pharma, Inc.Enrollment54Motor Neuron Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Honor Health Research Institute

    Scottsdale, Arizona, United States

  • Mayo Clinic

    Scottsdale, Arizona, United States

  • California Pacific Medical Center

    Sacramento, California, United States

  • University of California - Davis

    Sacramento, California, United States

  • University of California San Francisco

    San Francisco, California, United States

  • University of Colorado

    Aurora, Colorado, United States

  • Hospital for Special Care

    New Britain, Connecticut, United States

  • Gw Medical Faculty Associates Inc.

    Washington D.C., District of Columbia, United States

  • Mayo Clinic

    Jacksonville, Florida, United States

  • University of South Florida Health

    Tampa, Florida, United States

  • Emory University

    Atlanta, Georgia, United States

  • Indiana University Neuroscience Center

    Indianapolis, Indiana, United States

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, United States

  • Johns Hopkins Hospital

    Baltimore, Maryland, United States

  • Lahey Hospital and Medical Center

    Burlington, Massachusetts, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Saint Louis University

    St Louis, Missouri, United States

  • Hospital for Special Surgery

    New York, New York, United States

  • Guilford Neurologic Associates

    Greensboro, North Carolina, United States

  • Wake Forest University

    Winston-Salem, North Carolina, United States

  • Oregon Health Sciences University

    Portland, Oregon, United States

  • Providence Brain and Spine Institute

    Portland, Oregon, United States

  • Penn State Milton S. Hershey Medical Center

    Hershey, Pennsylvania, United States

  • Temple University

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Austin Neuromuscular Center

    Austin, Texas, United States

  • Baylor Scott and White Health

    Round Rock, Texas, United States

  • Ut Health San Antonio

    San Antonio, Texas, United States

  • the University of Utah

    Salt Lake City, Utah, United States

  • University of Vermont Medical Center

    Burlington, Vermont, United States

  • Virginia Commonwealth University

    Richmond, Virginia, United States

  • Saint Luke'S Rehabilitation Institute

    Spokane, Washington, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Jul 2017
Primary completion
27 Jul 2018
Completion
27 Jul 2018
Last update posted
29 Aug 2018
Registered enrollment
54
Registry id
NCT03196375

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.